Globus Medical (GMED) Restructuring Costs (2016 - 2025)
Globus Medical's Restructuring Costs history spans 11 years, with the latest figure at $10.8 million for Q4 2025.
- For Q4 2025, Restructuring Costs fell 36.65% year-over-year to $10.8 million; the TTM value through Dec 2025 reached $42.3 million, up 42.88%, while the annual FY2025 figure was $42.3 million, 42.88% up from the prior year.
- Restructuring Costs reached $10.8 million in Q4 2025 per GMED's latest filing, up from -$2.7 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $33.2 million in Q2 2025 to a low of -$8.6 million in Q4 2021.
- Average Restructuring Costs over 5 years is $5.0 million, with a median of $1.9 million recorded in 2022.
- The largest YoY upside for Restructuring Costs was 24667.86% in 2021 against a maximum downside of 362.11% in 2021.
- A 5-year view of Restructuring Costs shows it stood at -$8.6 million in 2021, then soared by 148.6% to $4.2 million in 2022, then skyrocketed by 273.38% to $15.6 million in 2023, then rose by 9.67% to $17.1 million in 2024, then crashed by 36.65% to $10.8 million in 2025.
- Per Business Quant, the three most recent readings for GMED's Restructuring Costs are $10.8 million (Q4 2025), -$2.7 million (Q3 2025), and $33.2 million (Q2 2025).